The role of MECP2 in lymphocyte proliferation was previously demonstrated in cultured clonal T cells from patients with RTT, where MECP2 deficiency led to a growth disadvantage and a blunted response to mitogen stimulus (Balmer et al., 2002). This evidence concerns the gene MECP2 and Rett syndrome.